Trial Profile
Double blind, randomised, placebo controlled trial of Sativex for the management of cannabis withdrawal
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Substance withdrawal syndrome
- Focus Therapeutic Use
- 15 Oct 2015 New trial record